Title: B3 Labs: Growing CBD Company Stands Out with Certification and Innovation
B3 Labs is a CBD company that has experienced remarkable growth in recent years. The company’s success can be attributed to its certification and commitment to innovation. B3 Labs has set itself apart from its competitors by obtaining the prestigious BRCGS certification, which guarantees compliance, safety, traceability, and legality.
This certification allows B3 Labs to provide assurance to both retailers and consumers that their CBD products are safe and meet the highest industry standards. In fact, B3 Labs is the only CBD company that has achieved this certification, further highlighting its commitment to quality.
The company’s dedication to excellence has not gone unnoticed in the industry. B3 Labs supplies products to four of the largest brands in the CBD industry, including the best-selling brand on Amazon. This recognition, coupled with their BRCGS certification, has propelled B3 Labs to new heights. They are projected to achieve a turnover of £3 million this year.
To keep up with the growing demand for their products, B3 Labs has recently moved to new, larger premises. This expansion reflects the company’s commitment to meeting customer needs and delivering their high-quality CBD products on a larger scale. Additionally, B3 Labs has been selected as one of the winners of the “Startup Stars” competition at the NutraIngredients’ Active Nutrition Summit in Amsterdam. This recognition allows B3 Labs to present their innovative business model to industry experts, cementing their position as a leader in the CBD market.
Founder and CEO, Marc Burbidge, recognizes the shifting consumer mindset when it comes to CBD products. Previously, people would purchase CBD specifically for medical needs. However, there has been a significant shift in recent years, with consumers seeking CBD products for general well-being and anxiety relief. Burbidge emphasizes the importance of extracting the right cannabinoids and formulating them with botanical ingredients to create highly bioavailable formulations that deliver targeted effects.
Despite the restrictions imposed by legislation on CBD product development, B3 Labs is continuously innovating. Instead of solely focusing on CBD, the company has turned its attention to other botanicals. Burbidge aims to enhance the efficacy of different parts of medicinal plants and increase bioavailability. B3 Labs’ new facility provides the perfect environment for developing cutting-edge delivery systems, such as liposomal emulsions and nano-emulsions. These advancements have the potential to significantly improve the bioavailability of ingredients, ensuring that consumers can fully benefit from the therapeutic properties of CBD and other botanicals.
Looking to the future, B3 Labs is exploring new avenues for growth. They are particularly interested in developing a line of nootropic gummies and extracting adaptogenic compounds from mushrooms. Burbidge identifies women’s health and cognitive health as trending areas within the wellness industry. Shomi Malik, the company’s commercial and strategy lead, believes that consumers are increasingly seeking products that target specific health goals rather than simply following trends. To attract these increasingly informed consumers, Malik emphasizes the importance of brands focusing on the science and mechanisms behind their ingredients.
In conclusion, B3 Labs is a CBD company that continues to excel in the industry through its BRCGS certification and commitment to innovation. Their success is driven by a focus on quality, safety, and delivering targeted effects to meet the evolving needs of consumers. With a growing customer base, a new state-of-the-art facility, and a strategic vision for the future, B3 Labs is poised to remain a leader in the ever-expanding CBD market.
0 Comments